Table 2

Procedural variables

 Before matchingAfter matching
Early discharge (n=107)Late discharge (n=358)p ValueEarly discharge (n=89)Late discharge (n=178)p Value
Edwards-SAPIEN
 23 mm17 (15.9)47 (13.2)0.47415 (16.9)20 (11.2)0.200
 26 mm15 (14.0)38 (10.6)0.33611 (12.4)25 (14.0)0.704
 29 mm2 (1.9)8 (2.2)0.5860 (0.0)7 (3.9)0.056
CoreValve
 23 mm4 (3.7)12 (3.4)0.5234 (4.5)5 (2.8)0.348
 26 mm26 (24.3)137 (38.4)0.00725 (28.1)69 (38.8)0.085
 29 mm33 (30.8)98 (27.5)0.49427 (30.3)44 (24.7)0.327
 31 mm7 (6.5)14 (3.9)0.1854 (4.5)8 (4.5)0.633
Lotus
 23 mm2 (1.9)0 (0.0)0.0531 (1.1)0 (0.0)0.333
 27 mm0 (0.0)1 (0.3)0.7700 (0.0)0 (0.0)
Portico
 23 mm1 (0.9)0 (0.0)0.2302 (2.2)0 (0.0)0.110
 25 mm0 (0.0)1 (0.3)0.7700 (0.0)0 (0.0)
TOE guidance0 (0.0)5 (1.4)0.4590 (0.0)1 (0.6)0.667
General anaesthesia2 (1.9)6 (1.7)0.4511 (1.1)1 (0.6)0.556
Device success*89 (83.2)300 (83.8)0.87975 (84.3)151 (84.8)0.904
Bailout THV-in-THV2 (1.9)9 (2.5)0.5172 (2.2)5 (2.8)0.571
THV embolisation1 (0.9)6 (1.7)0.4951 (1.1)1 (0.6)0.556
PVR more than mild13 (12.1)39 (11.0)0.73110 (11.2)20 (11.2)1.000
  • Values are n (%). Categorical variables were compared using the McNemar's exact test.

  • *Defined according to Valve Academic Research Consortium-2 (VARC-2) criteria.

  • PVR, paravalvular regurgitation; THV, transcatheter heart valve; TOE, transoesophageal echocardiogram.